Retroperitoneal lymph node recurrence of epithelial ovarian cancer: Prognostic factors and treatment outcome
Authors:
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 157 (2) , 392-397
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prognostic Factors and Clinical Outcome of Patients With Recurrent Early-Stage Epithelial Ovarian Cancer An Italian Multicenter Retrospective StudyInternational Journal of Gynecological Cancer, 2013
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcomeBMC Cancer, 2008
- Ovarian cancer patients with “node-positive-only” Stage IIIC disease have a more favorable outcome than Stage IIIA/BGynecologic Oncology, 2007
- Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgeryInternational Journal of Gynecological Cancer, 2007
- Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancerGynecologic Oncology, 2007
- Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factorsGynecologic Oncology, 2007
- Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?Gynecologic Oncology, 2006
- Outcomes After Combined Therapy Including Surgical Resection in Patients with Epithelial Ovarian Cancer Recurrence(s) Exclusively in Lymph NodesAnnals of Surgical Oncology, 2004
- The Validity and Significance of Substage IIIC by Node Involvement in Epithelial Ovarian Cancer: Impact of Nodal Metastasis on Patient SurvivalGynecologic Oncology, 1999